DNAシーケンスの市場規模、シェア、動向分析レポート：製品・サービス別、技術別、ワークフロー別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

DNAシーケンス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のDNAシーケンシング市場規模は、2024年から2030年にかけて21.65％のCAGRで拡大し、2030年には482億2,000万米ドルに達する見込みです。

人工知能（AI）を取り入れることで、臨床現場におけるゲノムデータの有用性が高まり、ゲノムデータ解析の進歩に新たなフロンティアが生まれます。2020年5月、Nvidia Corporationは、COVID-19の研究活動を支援するために、新しいAIツール、ゲノムシーケンシングソフトウェア、音声認識技術を開発しました。このように、AIは臨床診断におけるバリアントのアノテーションと優先順位付けを加速し、市場を牽引します。

ヒトゲノム・プロジェクトの完了以来、DNA配列決定コストは急激に低下しています。1人のゲノムを解読するコストは、10年前には約5万米ドルでしたが、現在、最大のゲノムセンターでは600米ドル近くに達しています。最近では、2020年2月にBGIがゲノム配列の解読費用を100ドルに引き下げると主張しています。これにより、出生前検査、がん検診、調査研究への利用が拡大すると期待されています。

コストの大幅な低下と資金調達の可能性が相まって、複数の新興企業が市場に参入しています。例えば、2020年1月、米国の新興企業であるOmniome社は、同社の遺伝子シーケンスプラットフォームの後期製品開拓と製品発売を加速させるため、シリーズC資金調達で6,000万米ドルを調達し、結果的に市場拡大を後押ししています。

DNAシーケンス市場のレポートハイライト

• コンサルティングサービス、トレーニングコース、顧客サポートとともに、手頃な価格でサービスを利用できるようになったことが、予測期間中、サービス分野を最も速い成長率で牽引すると予測されます。
• 新システムの発売による第3世代技術の絶え間ない技術進歩が、このセグメントを有利なCAGRで牽引すると予想されます。
• 例えば、2019年7月、Oxford Nanoporeは、同社のGridION X5システムの性能を向上させるベンチトップ、フレキシブルNGS、データ解析装置であるGridION Mk1を発売しました。
• ワークフローに基づくと、データ解析ステップは予測期間を通じてかなりのCAGRを記録すると予測されています。
• HTS-flowを搭載したワークフロー管理システムの登場は、ラボ管理システムからデータを取得し、シンプルなGUIでデータ解析を管理することで、データ解析ワークフローを効率化します。
• これらの技術は、がん診断薬や治療薬の開発のために遺伝子変異の配列を決定し、カタログ化するために、腫瘍学分野で広く受け入れられています。
• 世界のがん患者の増加が、腫瘍学の需要を牽引しています。米国では2020年に新たに180万人近くのがん患者が発生すると推定されています。
• 予測期間中、臨床研究分野が最も速い成長率を示すと予測され、次いで病院とクリニックが続く。
• COVID-19診断のための病院や診断センターにおけるNGSベースの診断検査へのアクセスを拡大するために企業や政府機関が行っている取り組みが、病院・診療所セグメントを有利なペースで牽引すると予想されます。
• アジア太平洋では、これらのツールの使用を伴う数多くの研究プログラムのおかげで、市場は予測期間中に最も高いCAGRで進展すると予想されています。
• 例えば、2019年10月、シンガポール科学技術研究庁ゲノム研究所の研究者は、希少疾患の診断を支援するために、アジア集団の最大の遺伝子データバンクを作成しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 DNAシーケンス市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/補助的な市場見通し。
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• DNAシーケンス市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • COVID-19感染症の影響分析

第4章 DNAシーケンス市場：製品およびサービスの推定・動向分析

• 製品およびサービスの市場シェア、2023年および2030年
• 市場規模、予測、動向分析、2018年から2030年まで
  • 消耗品
  • 器具
  • サービス

第5章 DNAシーケンス市場：技術推定・動向分析

• テクノロジー市場シェア、2023年と2030年
• 市場規模、予測、動向分析、2018年から2030年まで
  • サンガー法
  • NGS
  • 第三世代シーケンシング

第6章 DNAシーケンス市場：ワークフローの推定・動向分析

• ワークフロー市場シェア、2023年と2030年
• 市場規模、予測および動向分析、2018年から2030年まで
  • プレ・シーケンス
  • シーケンシング
  • データ分析

第7章 DNAシーケンス市場：用途の推定・動向分析

• 用途市場シェア、2023年と2030年
• 市場規模、予測および動向分析、2018年から2030年まで
  • 腫瘍学
  • リプロダクティブヘルス
  • 臨床試験
  • アグリゲノミクス・法医学
  • HLAタイピング
  • メタゲノミクス・疫学・薬の発達
  • コンシューマーゲノミクス
  • その他

第8章 DNAシーケンス市場： 最終用途推定・動向分析

• 最終用途市場シェア、2023年および2030年
• 市場規模、予測および動向分析、2018年から2030年まで

第9章 DNAシーケンス市場：地域推定・動向分析

• 地域市場シェア分析、2023年および2030年
• 北米
  • 2018年から2030年の北米市場推計・予測
  • 米国
  • カナダ
• 欧州
  • 2018年から2030年の欧州市場推計・予測
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋地域
  • 2018年から2030年のアジア太平洋市場推計・予測
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • 2018年から2030年のラテンアメリカ市場推計・予測
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • MEA市場推計・予測
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第10章 競合情勢

• 会社/競合の分類
• 戦略マッピング
• 企業の市況分析、2023年
• 企業プロファイル・一覧表
  • Thermo Fisher Scientific, Inc
  • Agilent Technology
  • Illumina, Inc.
  • QIAGEN
  • F. Hoffmann-La Roche Ltd.
  • Oxford Nanopore Technologies plc.
  • Macrogen, Inc.
  • PerkinElmer Genomics
  • PacBio
  • BGI
  • Bio-Rad Laboratories, Inc.
  • Myriad Genetics
  • PierianDx
  • Partek Incorporated
  • Eurofins Scientific

List of Tables

• Table 1 List of abbreviation
• Table 2 Global DNA sequencing market, by region, 2018 - 2030 (USD Million)
• Table 3 Global DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 4 Global DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 5 Global DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 6 Global DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 7 Global DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 8 North America DNA sequencing market, by country, 2018 - 2030 (USD Million)
• Table 9 North America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 10 North America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 11 North America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 12 North America DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 13 North America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 14 U.S. DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 15 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 16 U.S. DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 17 U.S. DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 18 U.S. DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 19 Canada DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 20 Canada DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 21 Canada DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 22 Canada DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 23 Canada DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Europe DNA sequencing market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 26 Europe DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 27 Europe DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 28 Europe DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 29 U.S. DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 30 Germany DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 31 Germany DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 32 Germany DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 33 Germany DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 34 Germany DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 35 UK DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 36 UK DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 37 UK DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 38 UK DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 39 UK DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 40 France DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 41 France DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 42 France DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 43 France DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 44 France DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 45 Italy DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 46 Italy DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 47 Italy DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 48 Italy DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Italy DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 50 Spain DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 51 Spain DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 52 Spain DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 53 Spain DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 54 Spain DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 55 Denmark DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 56 Denmark DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 57 Denmark DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 58 Denmark DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 59 Denmark DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 60 Sweden DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 61 Sweden DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 62 Sweden DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 63 Sweden DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 64 Sweden DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 65 Norway DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 66 Norway DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 67 Norway DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 68 Norway DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Norway DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 70 Asia Pacific DNA sequencing market, by country, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 74 Asia Pacific DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 75 Asia Pacific DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 76 China DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 77 China DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 78 China DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 79 China DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 80 China DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 81 Japan DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 82 Japan DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 83 Japan DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 84 Japan DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 85 Japan DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 86 India DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 87 India DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 88 India DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 89 India DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 90 India DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 91 South Korea DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 92 South Korea DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 93 South Korea DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 94 South Korea DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 95 South Korea DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 96 Australia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 97 Australia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 98 Australia DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 99 Australia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 100 Australia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 101 Thailand DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 102 Thailand DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 103 Thailand DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 104 Thailand DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 105 Thailand DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 106 Latin America DNA sequencing market, by country, 2018 - 2030 (USD Million)
• Table 107 Latin America DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 108 Latin America DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 109 Latin America DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 110 Latin America DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 111 Latin America DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 112 Brazil DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 113 Brazil DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 114 Brazil DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 115 Brazil DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 116 Brazil DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 117 Mexico DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 118 Mexico DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 119 Mexico DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 120 Mexico DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 121 Mexico DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 122 Argentina DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 123 Argentina DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 124 Argentina DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 125 Argentina DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 126 Argentina DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 127 MEA DNA sequencing market, by country, 2018 - 2030 (USD Million)
• Table 128 MEA DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 129 MEA DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 130 MEA DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 131 MEA DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 132 MEA DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 133 South Africa DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 134 South Africa DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 135 South Africa DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 136 South Africa DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 137 South Africa DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 142 Saudi Arabia DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 143 UAE DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 144 UAE DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 145 UAE DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 146 UAE DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 147 UAE DNA sequencing market, by workflow, 2018 - 2030 (USD Million)
• Table 148 Kuwait DNA sequencing market, by product & service, 2018 - 2030 (USD Million)
• Table 149 Kuwait DNA sequencing market, by technology, 2018 - 2030 (USD Million)
• Table 150 Kuwait DNA sequencing market, by application, 2018 - 2030 (USD Million)
• Table 151 Kuwait DNA sequencing market, by end-use, 2018 - 2030 (USD Million)
• Table 152 Kuwait DNA sequencing market, by workflow, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 DNA sequencing market: market outlook
• Fig. 9 DNA sequencing segment snapshot
• Fig. 10 DNA sequencing competitive insights
• Fig. 11 Parent market outlook
• Fig. 12 DNA sequencing market driver impact
• Fig. 13 DNA sequencing market restraint impact
• Fig. 14 DNA sequencing market: Product & service outlook and key takeaways
• Fig. 15 DNA sequencing market: Product & service movement analysis
• Fig. 16 Instruments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Services market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 DNA sequencing market: technology outlook and key takeaways
• Fig. 20 DNA sequencing market: technology movement analysis
• Fig. 21 Sanger sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Next-Generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Whole Genome Sequencing (WGS) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 24 Whole Exome Sequencing (WES) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Targeted sequencing & resequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Third generation sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Single-Molecule Real-Time Sequencing (SMRT) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Nanopore sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 DNA sequencing market: workflow outlook and key takeaways
• Fig. 30 DNA sequencing market: workflow movement analysis
• Fig. 31 Pre-sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Sequencing market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Data analysis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 DNA sequencing market: application outlook and key takeaways
• Fig. 35 DNA sequencing market: application movement analysis
• Fig. 36 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Reproductive health market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Clinical investigation market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 39 Agrigenomics & forensics market estimates and forecasts,2018 - 2030 (USD Million)
• Fig. 40 HLA typing/immune system monitoring market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Metagenomics, epidemiology & drug development market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Consumer genomics market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 DNA sequencing market: end-use outlook and key takeaways
• Fig. 45 DNA sequencing market: end-use movement analysis
• Fig. 46 Academic research market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Clinical research market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Hospitals & Clinics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Pharmaceutical & biotechnology companies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 50 Other users market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Global DNA sequencing market: Regional movement analysis
• Fig. 52 Global DNA sequencing market: Regional outlook and key takeaways
• Fig. 53 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Norway market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Japan market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 73 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Middle East and Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

DNA Sequencing Market Growth & Trends:

The global DNA sequencing market size is expected to reach USD 48.22 billion by 2030, expanding at a CAGR of 21.65% from 2024 to 2030, according to a new report by Grand View Research, Inc. The incorporation of Artificial Intelligence (AI) has increased the utility of genomic data in clinical practices and thus creates a new frontier in the advancement of genomic data analysis. In May 2020, Nvidia Corporation developed new AI tools, genomic sequencing software, and speech recognition technologies to aid the COVID-19 research efforts. Thus, AI accelerates the variant annotation and prioritization in the clinical diagnosis, which drives the market.

Since the completion of the Human Genome Project, the DNA sequencing cost has declined precipitously. The cost of decoding one person's genome was around USD 50,000 a decade ago and currently has reached nearly USD 600 in the largest genomic centers. Recently, in February 2020, BGI claimed to reduce the cost to sequence the genome to USD 100. This is expected to expand the use of this technology for prenatal tests, cancer screening, and research studies.

With a significant decrease in cost coupled with the availability of funding, several start-ups have entered the market. For instance, in January 2020, Omniome, a startup firm from the U.S., raised USD 60.0 million in Series C financing to speed up the late-stage product development and product launch of its genetic sequencing platform, which consequently fuels market progression.

DNA Sequencing Market Report Highlights:

• Rise in the availability of services at affordable prices along with consulting services, training courses, and customer support are anticipated to drive the services segment at the fastest growth rate over the forecast period
• Constant technological advancements in third-generation techniques with the launch of new systems are expected to drive this segment at a lucrative CAGR
• For instance, in July 2019, Oxford Nanopore launched GridION Mk1, a benchtop, flexible NGS, data analysis device that improves the performance of the company's GridION X5 system
• On the basis of workflow, the data analysis step is anticipated to register a considerable CAGR throughout the forecast period
• The advent of workflow management systems with HTS-flow retrieves data from laboratory management systems and manages data analysis through a simple graphical user interface, subsequently streamlining the data analysis workflow
• These technologies are widely accepted in the oncology field to sequence and catalog gene mutations for the development of cancer diagnostic and therapeutics
• A rise in cancer cases globally is driving demand for oncology. It is estimated that there would be nearly 1.8 million new cancer cases in 2020 in the U.S.
• The clinical research segment is projected to witness the fastest growth rate over the forecast period, followed by hospitals and clinics
• Efforts undertaken by companies and government agencies to broaden the accessibility for NGS-based diagnostic tests in the hospitals and diagnostic centers for COVID-19 diagnosis is anticipated to drive the hospitals and clinics segment at a lucrative pace
• In Asia Pacific, the market is expected to progress with the highest CAGR over the forecast period owing to numerous research programs that involve the usage of these tools
• For instance, in October 2019, researchers from the Agency for Science, Technology and Research's Genome Institute of Singapore created the largest genetic databank of Asian populations to support the diagnosis of rare diseases

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product & Service
  • 1.2.2. Technology
  • 1.2.3. Workflow
  • 1.2.4. Application
  • 1.2.5. End-use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. DNA Sequencing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Technological advancements in sequencing techniques
    • 3.2.1.2. Rising interest in genomics research and personalized medicine
    • 3.2.1.3. Increasing applications of DNA sequencing in clinical diagnostics
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Data storage and management challenges
    • 3.2.2.2. Ethical and privacy concerns related to the use of sequencing technologies.
• 3.3. DNA Sequencing Market Analysis Tools
  • 3.3.1. Industry analysis - Porter's
  • 3.3.2. PESTEL analysis
  • 3.3.3. COVID-19 impact analysis

Chapter 4. DNA Sequencing Market: Product & Service Estimates & Trend Analysis

• 4.1. Product & Service Market Share, 2023 & 2030
• 4.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
  • 4.2.1. Consumables
    • 4.2.1.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.2.2. Instruments
    • 4.2.2.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.2.3. Services
    • 4.2.3.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. DNA Sequencing Market: Technology Estimates & Trend Analysis

• 5.1. Technology Market Share, 2023 & 2030
• 5.2. Market Size & Forecasts And Trend Analyses, 2018 To 2030 For The Following
  • 5.2.1. Sanger sequencing
    • 5.2.1.1. Sanger sequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.2.2. Next-generation sequencing (NGS)
    • 5.2.2.1. Next-generation sequencing (NGS) market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.2.2. Whole genome sequencing (WGS)
    • 5.2.2.2.1. Whole genome sequencing (WGS) market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.2.3. Whole exome sequencing (WES)
    • 5.2.2.3.1. Whole exome sequencing (WES) market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.2.4. Targeted sequencing & resequencing
    • 5.2.2.4.1. Targeted sequencing & resequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.2.3. Third generation dna sequencing
    • 5.2.3.1. Third generation dna sequencing market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.3.2. Single-molecule real-time sequencing (SMRT)
    • 5.2.3.2.1. Single-molecule real-time sequencing (SMRT) market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.2.3.3. Nanopore sequencing
    • 5.2.3.3.1. Nanopore sequencing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. DNA Sequencing Market: Workflow Estimates & Trend Analysis

• 6.1. Workflow Market Share, 2023 & 2030
• 6.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.2.1. Pre-sequencing
    • 6.2.1.1. Pre-sequencing market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.2.2. Sequencing
    • 6.2.2.1. Sequencing Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.2.3. Data Analysis
    • 6.2.3.1. Data analysis Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. DNA Sequencing Market: Application Estimates & Trend Analysis

• 7.1. Application Market Share, 2023 & 2030
• 7.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.2.1. Oncology
    • 7.2.1.1. Oncology Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.2.2. Reproductive Health
    • 7.2.2.1. Reproductive health market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.2.3. Clinical Investigation
    • 7.2.3.1. Clinical investigation Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.2.4. Agrigenomics & Forensics
    • 7.2.4.1. Agrigenomics & forensics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.2.5. HLA Typing/Immune System Monitoring
    • 7.2.5.1. HLA Typing/Immune System Monitoring market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.2.6. Metagenomics, Epidemiology, & Drug Development
    • 7.2.6.1. Metagenomics, epidemiology, & drug development market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.2.7. Consumer Genomics
    • 7.2.7.1. Consumer genomics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.2.8. Others
    • 7.2.8.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. DNA Sequencing Market: End-use Estimates & Trend Analysis

• 8.1. End-use Market Share, 2023 & 2030
• 8.2. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 8.2.1. Academic Research
    • 8.2.1.1. Academic research market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.2.2. Clinical Research
    • 8.2.2.1. Clinical research market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.2.3. Hospitals & Clinics
    • 8.2.3.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.2.4. Pharmaceutical & Biotechnology Companies
    • 8.2.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.2.5. Others
    • 8.2.5.1. Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. DNA Sequencing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Market Share Analysis, 2023 & 2030
• 9.2. North America
  • 9.2.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.2.2. U.S.
    • 9.2.2.1. Key country dynamics
    • 9.2.2.2. Regulatory framework
    • 9.2.2.3. Target disease prevalence
    • 9.2.2.4. Competitive scenario
    • 9.2.2.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.2.3. Canada
    • 9.2.3.1. Key country dynamics
    • 9.2.3.2. Regulatory framework
    • 9.2.3.3. Target disease prevalence
    • 9.2.3.4. Competitive scenario
    • 9.2.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 9.3. Europe
  • 9.3.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.2. UK
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework
    • 9.3.2.3. Target disease prevalence
    • 9.3.2.4. Competitive scenario
    • 9.3.2.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.3. Germany
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework
    • 9.3.3.3. Target disease prevalence
    • 9.3.3.4. Competitive scenario
    • 9.3.3.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.4. France
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Regulatory framework
    • 9.3.4.3. Target disease prevalence
    • 9.3.4.4. Competitive scenario
    • 9.3.4.5. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.5. Italy
    • 9.3.5.1. Key country dynamics
    • 9.3.5.2. Regulatory framework
    • 9.3.5.3. Target disease prevalence
    • 9.3.5.4. Competitive scenario
    • 9.3.5.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.6. Spain
    • 9.3.6.1. Key country dynamics
    • 9.3.6.2. Regulatory framework
    • 9.3.6.3. Target disease prevalence k
    • 9.3.6.4. Competitive scenario
    • 9.3.6.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.7. Norway
    • 9.3.7.1. Key country dynamics
    • 9.3.7.2. Regulatory framework
    • 9.3.7.3. Target disease prevalence
    • 9.3.7.4. Competitive scenario
    • 9.3.7.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.8. Sweden
    • 9.3.8.1. Key country dynamics
    • 9.3.8.2. Regulatory framework
    • 9.3.8.3. Target disease prevalence
    • 9.3.8.4. Competitive scenario
    • 9.3.8.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.3.9. Denmark
    • 9.3.9.1. Key country dynamics
    • 9.3.9.2. Regulatory framework
    • 9.3.9.3. Target disease prevalence
    • 9.3.9.4. Competitive scenario
    • 9.3.9.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.4. Asia Pacific
  • 9.4.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. Japan
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Target disease prevalence
    • 9.4.2.4. Competitive scenario
    • 9.4.2.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. China
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Target disease prevalence
    • 9.4.3.4. Competitive scenario
    • 9.4.3.5. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. India
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Target disease prevalence
    • 9.4.4.4. Competitive scenario
    • 9.4.4.5. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.5. Australia
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework
    • 9.4.5.3. Target disease prevalence
    • 9.4.5.4. Competitive scenario
    • 9.4.5.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.6. South Korea
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework
    • 9.4.6.3. Target disease prevalence
    • 9.4.6.4. Competitive scenario
    • 9.4.6.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.7. Thailand
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework
    • 9.4.7.3. Target disease prevalence
    • 9.4.7.4. Competitive scenario
    • 9.4.7.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Latin America
  • 9.5.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. Brazil
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Target disease prevalence
    • 9.5.2.4. Competitive scenario
    • 9.5.2.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Mexico
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Target disease prevalence
    • 9.5.3.4. Competitive scenario
    • 9.5.3.5. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. Argentina
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Target disease prevalence
    • 9.5.4.4. Competitive scenario
    • 9.5.4.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. MEA
  • 9.6.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. South Africa
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Target disease prevalence
    • 9.6.2.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. Saudi Arabia
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. Target disease prevalence
    • 9.6.3.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. UAE
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Target disease prevalence
    • 9.6.4.4. Competitive scenario
    • 9.6.4.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Kuwait
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Target disease prevalence
    • 9.6.5.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2023
• 10.4. Company Profiles/Listing
  • 10.4.1. Thermo Fisher Scientific, Inc
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product & service benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Agilent Technology
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product & service benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Illumina, Inc.
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product & service benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. QIAGEN
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product & service benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. F. Hoffmann-La Roche Ltd.
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product & service benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Oxford Nanopore Technologies plc.
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product & service benchmarking
    • 10.4.6.4. Strategic initiatives
  • 10.4.7. Macrogen, Inc.
    • 10.4.7.1. Company overview
    • 10.4.7.2. Financial performance
    • 10.4.7.3. Product & service benchmarking
    • 10.4.7.4. Strategic initiatives
  • 10.4.8. PerkinElmer Genomics
    • 10.4.8.1. Company overview
    • 10.4.8.2. Financial performance
    • 10.4.8.3. Product & service benchmarking
    • 10.4.8.4. Strategic initiatives
  • 10.4.9. PacBio
    • 10.4.9.1. Company overview
    • 10.4.9.2. Financial performance
    • 10.4.9.3. Product & service benchmarking
    • 10.4.9.4. Strategic initiatives
  • 10.4.10. BGI
    • 10.4.10.1. Company overview
    • 10.4.10.2. Financial performance
    • 10.4.10.3. Product & service benchmarking
    • 10.4.10.4. Strategic initiatives
  • 10.4.11. Bio-Rad Laboratories, Inc.
    • 10.4.11.1. Company overview
    • 10.4.11.2. Financial performance
    • 10.4.11.3. Product & service benchmarking
    • 10.4.11.4. Strategic initiatives
  • 10.4.12. Myriad Genetics
    • 10.4.12.1. Company overview
    • 10.4.12.2. Financial performance
    • 10.4.12.3. Product & service benchmarking
    • 10.4.12.4. Strategic initiatives
  • 10.4.13. PierianDx
    • 10.4.13.1. Company overview
    • 10.4.13.2. Financial performance
    • 10.4.13.3. Product & service benchmarking
    • 10.4.13.4. Strategic initiatives
  • 10.4.14. Partek Incorporated
    • 10.4.14.1. Company overview
    • 10.4.14.2. Financial performance
    • 10.4.14.3. Product & service benchmarking
    • 10.4.14.4. Strategic initiatives
  • 10.4.15. Eurofins Scientific
    • 10.4.15.1. Company overview
    • 10.4.15.2. Financial performance
    • 10.4.15.3. Product & service benchmarking
    • 10.4.15.4. Strategic initiatives